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Background  
The COVID-19 pandemic continues to present a major 
challenge for health services and society worldwide. 
Since the emergence of the SARS-CoV-2 virus, the re-
search community has shown an extraordinary response 
to the pandemic. This volume of information and rate 
of publication makes it exceedingly challenging for re-
search stakeholders (including researchers, funders, and 
policymakers) to efficiently identify studies relevant to 
their interests, evaluate the quality of those studies, and 
utilise their findings for health benefit (1). This “info-
demic”, along with the dissemination of unsubstanti-
ated claims in both lay and social media, risks fuelling 
a growing distrust in science and highlights the need for 
an accessible resource to support public understanding 
of, and access to, research findings.   
Evidence is incremental, and new experimental findings 
offer the greatest value when considered in the context 
of other studies that have addressed the same or related 
research questions in different settings. Systematic re-
views capture, summarise, and critically appraise the 
available evidence relevant to a pre-specified research 
question. They are considered the most effective method 
of reaching a rigorous understanding of the literature, 
and informing decision-making (2). Unfortunately, the 
time taken to perform traditional systematic reviews 
means that the findings are often outdated by the time 
of dissemination. The urgent need for evidence-based 
treatments for COVID-19 infection combined with a 
rapidly accumulating COVID-19 literature has made this 
an even greater challenge. Automation technologies (e.g. 
machine learning and text-mining) can be used to reduce 
the time and resources required. For example, we can 
train a machine to classify research as relevant or not rel-
evant to our research question, or to extract structured 
information from publications, at greatly reduced human 
effort (3-5). Such technologies facilitate the development 
of “Living” systematic reviews, in which new evidence is 
incorporated into the review as and when it becomes 
available (6, 7). Further, by incorporating crowdsourcing 
approaches to recruit and train external reviewers, a 
much larger team can work together to extract informa-
tion from publications at a faster pace.  
Building upon existing living review methodologies, we 
have developed and integrated a series of automation 
tools and methodologies for the continual collection, 
categorisation, and quality assessment of COVID-19 
evidence from primary research studies. We have built 
a Systematic Online Living Evidence Summary 
(SOLES) of all primary research relevant to COVID-
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19; an interactive web application, which allows users 
to interact with a visual summary of the curated infor-
mation, interrogate the dataset, and download relevant 
citations filtered by study characteristic of interest. This 
resource is intended for use by all stakeholders in 
COVID-19 research, including researchers working 
within the field or performing rapid or systematic re-
views of COVID-19 literature. 
 
METHODS    
Identifying new research papers 
To retrieve up-to-date research reports we retrieve cita-
tions weekly from PubMed (National Library of 
Medicine), Web of Science (all available databases: 
Web of Science Core Collection, BIOSIS Citation 
Index, Current Contents Connect, Data Citation 
Index, Derwent Innovations Index, KCI-Korean Jour-
nal Database, MEDLINE, Russian Science Citation 
Index, SciELO Citation Index, Zoological Record), 
EMBASE (OVID), and the World Health Organisa-
tion’s COVID-19 database (8). Our search terms are 
described in our study protocol and have been updated 
over time to address changes in COVID-19 research 
terminology (9). To identify new research from 
PubMed programmatically, we use the pubmedTools R 
package (10) developed within our group to access the 
Entrez application programming interface, while other 
records are obtained through manual searching of the 
platforms/databases outlined above .  
 
Duplicate removal  
To maintain a database of unique citations, we identify 
and remove duplicate citations (bibliographic dupli-
cates of work published in the same journal at the same 
time by the same authors) identified across different 
databases using an automated, R-based tool developed 
within our research group, the automated systematic 
search de-duplicator (11).  
 
Retrieving full text publications 
We retrieve full-text publications using custom R code 
(12) to access full-text portable document formats 
(PDFs) where we have institutional access (University 
of Edinburgh). The extraction code uses digital object 
identifiers (DOIs) to retrieve PDF links through Cross-
Ref, PubMed Central, and doi.org, then downloads the 
PDF file using the retrieved link. 
 
Crowdsourced study annotation 
To adequately capture the broad spectrum of primary 
COVID-19 research, we developed a schema (Figure 1) 
to classify research by type, objective, methods, and pa-
tient population/ sample type, based on previously pro-
posed definitions (13). Using these classifications, we 
Fig. 1. Research classification schema for primary COVID-19 studies. Arrows indicate a tree-like structure where reviews 
can only add subsequent annotations based on the previous annotation. 
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designed a project on the Systematic Review Facility 
(SyRF; http://syrf.org.uk/), a widely used and freely 
available online platform developed within our research 
group (14). SyRF facilitates the conduct of large, col-
laborative systematic review projects and allows users 
to design structured annotation forms with custom 
questions. Once the project plan had been finalised, 
three independent researchers within our group anno-
tated a test batch of 16 research papers. Through dis-
cussion, we arrived at a consensus on how each paper 
should be annotated. These annotations became our 
“gold-standard” annotated dataset used to train a 
crowdsourced team of human reviewers.  
To recruit a team of reviewers to annotate COVID-19 
research, we advertised the project via our social media 
profiles, existing contacts, and university research net-
works. Trainee reviewers were required to annotate a 
minimum of eight papers which were then checked 
against the gold-standard annotations. Once complete, 
we provided feedback and either asked trainees to com-
plete more training papers or allowed them to continue 
as a reviewer on the main project. To ensure quality, 
each article is annotated by two independent reviewers. 
To keep reviewers up to date, fortnightly progress re-
ports are sent out via email. Reports are generated pro-
grammatically with R code which interacts with SyRF 
and published online on the RPubs server as a living 
RMarkdown document (15).  
 
Integration with the Systematic Review Facility  
Subsets from our dataset of unique COVID-19 records 
are selected based on the date they are retrieved, with 
older records uploaded first. Custom R scripts are 
scheduled (using the CronR package) to periodically in-
teract with SyRF to obtain information on the number 
of reviewers working on the project, the number of 
studies annotated, and the annotations themselves. This 
allows us to keep an up-to-date record of progress.  
 
Reconciliation of annotations  
For each paper, annotations from two independent re-
viewers are compared using a custom R script. If review-
ers agree on whether the paper describes primary 
research relevant to COVID-19, this study is immediately 
classified as “included” or “excluded” – irrespective of 
whether they agree on all classifications. If reviewers do 
agree across all classifications, the study is classed as “rec-
onciled” and those classifications are final. If there are dis-
agreements on one or more annotations, the paper is 
passed to a senior reviewer who will reconcile the dis-
agreements before submitting a final set of classifications.  
 
Machine-assisted classification of primary 
studies 
We used the “included” or “excluded” decisions from 
reconciled annotations to train a machine learning al-
gorithm hosted by collaborators at The Evidence for 
Policy and Practice Information and Co-ordinating 
Centre (EPPI-Centre), University College London. 
The algorithm uses natural language processing to iden-
tify features within the Title and Abstract of citations. 
We aimed to train it to automatically classify non-an-
notated studies as either “primary COVID-19 research” 
or “other” research.  
 
Web application and dataset availability  
We built a user interface to access our entire COVID-
19 dataset via an R Shiny web application. The applica-
tion allows users to visualise the annotated evidence, 
search the citation database (using regular expressions), 
and download relevant citations. The COVID-SOLES 
application is freely available online (16).  
 
RESULTS 
COVID-SOLES citation database 
At the time of writing (May 2021) we have identified a 
total of 812,261 potentially relevant citations since our 
COVID-19 searches began in March 2020. The distri-
bution of records retrieved from each database is shown 
in Figure 2. We obtained the highest number of records 
from the WHO COVID-19 database (N= 246,299) and 
the lowest number from PubMed (N=129,973). 
Fig. 2. Total COVID-19 citations retrieved from each 
database per month. 
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Following extensive de-duplication 349,726 unique ci-
tations have been identified. Over time, the number of 
unique publications retrieved per month has increased, 
with a brief levelling off period over the new year. In 
May 2021, we identified 50,095 publications, the 
largest monthly publication count yet.  
 
Crowdsourced annotation 
We have recruited 88 trainee reviewers of which 78 have 
completed training and are able to annotate COVID-
19 publications. The median number of papers anno-
tated by each reviewer was 99 (interquartile range: 
70.75 – 173.75). Two reviewers were particularly active, 
annotating 1,874 and 6,597 publications, respectively.   
 
Machine classification of COVID-19 research 
From a total of 226,417 citations in our dataset which 
had abstracts, 3,405 had been classified by humans as 
“primary COVID-19 research” (N=1312) or “other” 
(N=2093). This dataset was randomly split into a train-
ing set, validation set, and test set. We used a pre-set 
sensitivity threshold of at least >95% to ensure we cap-
tured the majority of relevant publications. On the test 
set (N=681), the classifier performed at a sensitivity 
(percentage of citations correctly included) of 95.2%, a 
specificity (percentage of citations correctly excluded) 
of 76.6%, and precision (percentage of correctly in-
cluded citations from all included citations) of 71.9%. 
To date, the number of fully annotated primary studies 
is too low to train classifiers to identify specific objec-
tives or study methodologies (N=1,174). A summary 
of the primary studies annotated by objective and 
methodology is shown in Figure 4. Due to our chrono-
logical approach to annotating studies, this summary 
reflects COVID-19 research conducted early in the 
pandemic, in March and April 2020.  
 
Use of Web application 
Since we developed the COVID-SOLES application, it 
has been accessed over 1,700 times by users from 45 
countries.  
 
LIMITATIONS AND FUTURE WORK 
Optimising citation retrieval  
Some retrieved citations lack useful meta-data, such as  
 
Fig. 3. COVID-19 citations retrieved per month. Bars 
indicate unique citations retrieved across databases fol-
lowing the removal of duplicates. 
Fig. 4. COVID-SOLES database citations annotated by objective and methodology (N=1,174). Darker colours and 
larger bubble sizes indicate a higher number of publications. 
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DOI. This may be, in part, due to the uniquely chal-
lenging pace of COVID-19 research and our continual 
searching to retrieve newly published research. In some 
cases, we may be retrieving publications before they are 
fully indexed in biomedical databases. Figure 5 indicates 
the percentage of unique citations retrieved from each 
database that lacks digital object identifiers (DOIs). Of 
unique records retrieved from the WHO COVID-19 
database and Web of Science, 33.5% and 21.3% of ci-
tations are missing DOIs, respectively. To remedy this, 
we are now employing the rcrossref R package (17) to 
programmatically query the CrossRef database using ti-
tles and to identify the corresponding DOI information. 
Furthermore, we are refining our deduplication code to 
set a preference for retaining PubMed records over 
other databases, as 95.8% of citations we receive from 
PubMed have DOIs.  
Supplementing our study type annotations 
A major limitation is that we are not yet able to classify 
research automatically. The ability to do this as new re-
search emerges would provide us with insights into re-
search trends over time and identify gaps where more 
research may be needed.  To obtain more study type an-
notations to drive automatic study type detection, we 
aim to recruit more volunteers by launching a new cam-
paign across social media and other research networks. 
We are also exploring the possibility of exploiting anno-
tation data from other openly available systematic evi-
dence summaries of the COVID-19 literature and from 
published systematic reviews with accessible data. Past 
reviews have focused primarily on the clinical literature, 
so we will aim to make use of the existing data to clas-
sify human research and focus our crowd towards areas 
where there has been comparatively less attention e.g. 
in vivo research and in vitro research.  
Improving our user interface  
At present, some elements of the R Shiny user interface 
load slowly and it does not support full text searching 
of PDFs or Boolean searching of our database. We are 
currently building a new web interface to support these 
functionalities and sustain the growing COVID-SOLES 
database going forward.  
 
Conclusion 
We have developed a living workflow to synthesise 
COVID-19 research which enables research users to 
make rapid use of the currently available evidence. The 
SOLES workflow is sustainable, requiring minimal 
human effort to maintain – except the efforts of crowd-
sourced volunteers – and is transferrable to other re-
search areas. We will continue to improve upon this 
workflow, enable more automated categorisation tools, 
and upgrade the user interface to enable features most 
useful to the evidence synthesis community.  
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